BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6873999)

  • 1. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes.
    Isakov N; Segal S
    Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity.
    Isakov N; Feldman M; Segal S
    Immunobiology; 1982; 162(1):15-27. PubMed ID: 7106838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth.
    Isakov N; Feldman M; Segal S
    Cancer Res; 1981 Feb; 41(2):667-72. PubMed ID: 7448812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression.
    Hayashi T; Mori I; Yamamoto H
    Int J Exp Pathol; 1992 Oct; 73(5):593-601. PubMed ID: 1419777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection.
    Michaelides MC; Simms ES
    Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
    Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
    Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation of growth attenuation of murine lymphoma caused by in vitro passage with loss of lactate dehydrogenase virus.
    Johnson RJ; Shin HS
    J Natl Cancer Inst; 1983 Dec; 71(6):1337-41. PubMed ID: 6581366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes.
    Stevenson MM; Rees JC; Meltzer MS
    J Immunol; 1980 Jun; 124(6):2892-9. PubMed ID: 7373055
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
    Cafruny WA; Bradley SE; Rowland RR
    Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic dehydrogenase virus infection reduces the expulsion of the nematode Nippostrongylus brasiliensis.
    Morimoto M; Yamamoto N; Hayashi T
    Parasitol Res; 2003 Jun; 90(2):153-6. PubMed ID: 12756552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.
    Broen JJ; Cafruny WA
    Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
    Broen JB; Bradley DS; Powell KM; Cafruny WA
    Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice.
    Michaelides MC; Simms ES
    Immunology; 1977 Jun; 32(6):981-8. PubMed ID: 885591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H; Himeno K; Miake S; Nomoto K
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance.
    Hayashi T; Ozaki M; Mori I; Saito M; Itoh T; Yamamoto H
    Int J Exp Pathol; 1992 Apr; 73(2):173-81. PubMed ID: 1571277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.